Navigation Links
Microbiologists receive top Canadian recognition
Date:5/8/2008

One is a veteran researcher, the other new, but two microbiologists from The University of Western Ontario have both been singled out to receive national recognition for their work on infectious diseases and immunity from the Canadian Society of Microbiologists (CSM).

Dr. Miguel Valvano, a professor and Chair of the Department of Microbiology and Immunology at the Schulich School of Medicine & Dentistry received the prestigious CSM/Roche Diagnostics Award for outstanding accomplishments and Dr. John McCormick, an assistant professor in the Department of Microbiology received the Fisher Scientific Award for new researchers in microbiological sciences.

Valvano, who also holds a Canada Research Chair in Infectious Diseases and Microbial Pathogenesis, received his M.D. from the University of Buenos Aires, and trained as paediatrician and infectious diseases specialist in the Buenos Aires Childrens Hospital, and later as a molecular biologist in the Oregon Health Sciences University, before joining Western in 1988. His team discovered the way to kill B. cenocepacia, a superbug which can be highly contagious and deadly for those with cystic fibrosis. This discovery paves the way for the development of new antibiotics to treat it, as well as a vaccine to prevent it. We are investigating how bacteria make their outer surface and how can we find novel ways to interfere with this process, says Valvano.

A critical aspect of our research is also to train graduate students and postdoctoral fellows to become outstanding biomedical scientists within an environment of scientific inquiry, and particularly placing an emphasis on personal and scientific integrity and on team player skills.

McCormick received his Ph.D. from the University of Alberta and continued post-doctoral training in the U.S. before coming to Western in 2002. McCormick is also a scientist with the Lawson Health Research Institute and he holds a New Investigator award from the Canadian Institutes of Health Research and an Early Research award from the Ontario Ministry of Research and Innovation. Our research focuses primarily on a group of toxins called superantigens that are produced by the bacterial pathogens Streptococcus pyogenes and Staphylococcus aureus. These toxins induce a dramatic activation of the immune system and can cause a rare but very dangerous disease called toxic shock syndrome, explains McCormick. We use a number of advanced techniques in molecular biology, genetics, bacteriology, and immunology, to understand how these toxins function at a very detailed level, such that we rationally design inhibitors of their function, and also so that we can harness their function for immune based therapeutics.

The scientists will receive their awards June 9th in Calgary.


'/>"/>

Contact: Kathy Wallis
kwallis3@uwo.ca
519-661-2111 x81136
University of Western Ontario
Source:Eurekalert

Related medicine news :

1. U.S. Navy Receives Funding for Further Development of Hemopure(R)
2. UCSF receives funding for building from California stem cell agency
3. USC receives nearly $27 million in funding for new stem cell research facility
4. Amneal Pharmaceuticals Receives US FDA Approval for Three Generic Prescription Drugs; Two Using New FDA Electronic Filing Format
5. Presbyterian Hospital of Plano Receives Prestigious Texas Award for Performance Excellence
6. Boston Medical Center/Boston University School of Medicine researcher receives award
7. Canadian Company Receives Final Tender Approval From Rwanda For Vital AIDS Drug
8. Hospitals in Louisiana and Mississippi to Receive More Katrina Recovery Grants
9. Quatro Composites Receives ISO 9001:2000 and AS9100:2004 Certification
10. Vascular Insights Receives FDA Clearance for Infusion Catheter
11. Epitomics receives ISO 9001 certification for the production of Rabbit Monoclonal Antibodies.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... , ... October 13, 2017 , ... As health professionals ... known as “patient engagement.” The patient is doing more than filling out a survey; ... , “There is an increasing emphasis in health care and research on the importance ...
(Date:10/13/2017)... ... 13, 2017 , ... PurhealthRX , a leading Health and Nutrition Company, ... Purzorb™process to full spectrum CBD oil will revolutionize the rapidly growing CBD market by ... be easily incorporated into liquid products, while reducing costs to end users. , The ...
(Date:10/13/2017)... ... October 13, 2017 , ... Many families have long-term ... long-term care insurance companies have a waiver for care if the client has a ... when the family pays for care, is often waived, so the benefits from their ...
(Date:10/13/2017)... ... October 13, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The House ... most popular and least understood books in the Holy Scriptures, Revelation. The Book of ... baffled scholars for centuries. Many have tossed it off as mere rubbish, but Yisrayl ...
(Date:10/13/2017)... , ... October 13, 2017 , ... “America On The ... identity. “America On The Brink” is the creation of published author, William Nowers. ... great-grandchildren. As a WWII veteran, he spent thirty years in the Navy. ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... Oct. 2, 2017 Halo Labs announces the European launch ... called the HORIZON at MIBio 2017 in Cambridge, U.K ... visible particulate matter in biopharmaceutical samples with unprecedented speed and sensitivity ... novel technique Backgrounded Membrane Imaging. ... The HORIZON subvisible particle analysis system ...
(Date:9/27/2017)... 2017  Commended for their devotion to personalized service, SMP ... number one in the South Florida Business Journal,s 50 Fastest-Growing ... yearly list, the national specialty pharmacy has found its niche.  ... will soon be honored by SFBJ as the 2017 Power ... Set to receive his award in October, Bardisa said of ...
(Date:9/23/2017)... , Sept. 22, 2017 Janssen Biotech, ... complete response letter from the U.S. Food and Drug ... approval of sirukumab for the treatment of moderately to ... indicates additional clinical data are needed to further evaluate ... to severely active RA. ...
Breaking Medicine Technology: